Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Neoplasm of Gastrointestinal Tract”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT05009966
What this trial is testing

Study of SYSA1801 in the Treatment of Claudin( CLDN) 18.2 Positive Advanced Malignant Solid Tumor

Who this might be right for
Advanced Solid TumorGastric Cancer (GC)Gastroesophageal Junction (GEJ) Cancer+1 more
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 272
Not applicableStudy completedNCT00534131
What this trial is testing

Anterior Perineal Plane for Ultra Low Anterior Resection of the Rectum

Who this might be right for
Rectal NeoplasmsColitis, IschemicColitis, Ulcerative
Queen Mary University of London 23
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Early research (Phase 1)Active Not RecruitingNCT02298959
What this trial is testing

Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer

Who this might be right for
Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Colorectal CarcinomaMetastatic Malignant Solid Neoplasm+12 more
National Cancer Institute (NCI) 59
Testing effectiveness (Phase 2)Ended earlyNCT04785287
What this trial is testing

Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies

Who this might be right for
Advanced Lung CarcinomaAdvanced Malignant Solid NeoplasmMalignant Adrenal Gland Neoplasm+14 more
M.D. Anderson Cancer Center 13
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07576725
What this trial is testing

Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+40 more
Fred Hutchinson Cancer Center 50
Not applicableUnknownNCT06187610
What this trial is testing

Digital Delivery of Patient Education: A Case Study of Symptom Self-Management During Cancer Treatment

Who this might be right for
Digital Education InterventionsKnowledge Types (Mechanistic Versus Procedural)
Tel Aviv University 110
Testing effectiveness (Phase 2)Study completedNCT04426669
What this trial is testing

Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering

Who this might be right for
Gastrointestinal Epithelial CancerGastrointestinal NeoplasmsCancer of Gastrointestinal Tract+8 more
Intima Bioscience, Inc. 23
Not applicableStudy completedNCT03530969
What this trial is testing

Geriatric Communication Skills Training Program for Oncology Clinicians

Who this might be right for
GI CancerLymphomaGU Cancer+1 more
Memorial Sloan Kettering Cancer Center 88
Early research (Phase 1)Looking for participantsNCT06040541
What this trial is testing

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma (PDAC)+1 more
Revolution Medicines, Inc. 604
Testing effectiveness (Phase 2)Study completedNCT01037790
What this trial is testing

Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer

Who this might be right for
Adult Solid TumorAdenocarcinoma of the ColonAdenocarcinoma of the Rectum+36 more
Abramson Cancer Center at Penn Medicine 304
Testing effectiveness (Phase 2)Ended earlyNCT03439085
What this trial is testing

DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers

Who this might be right for
Human Papillomavirus-16 PositiveHuman Papillomavirus-18 PositiveMetastatic Malignant Neoplasm+18 more
M.D. Anderson Cancer Center 41
Testing effectiveness (Phase 2)Looking for participantsNCT05672108
What this trial is testing

Phase II Trial of Lung Chemoemobolization

Who this might be right for
Lung Non-Small Cell CarcinomaMediastinal NeoplasmPleural Neoplasm+4 more
City of Hope Medical Center 30
Not applicableNot Yet RecruitingNCT07661017
What this trial is testing

GutCheck: Optimization of a Personalized Mobile Health App for Survivors of Gastrointestinal Cancer

Who this might be right for
GastrointestinalMobile HealthGastrointestinal Symptoms+4 more
Masonic Cancer Center, University of Minnesota 200
Not applicableNot Yet RecruitingNCT07260617
What this trial is testing

Association Between Composition of the Gut Microbiota and Nutritional Status in Digestive Oncology

Who this might be right for
Digestive Cancer
Hospices Civils de Lyon 150
Early research (Phase 1)Looking for participantsNCT05227326
What this trial is testing

AOH1996 for the Treatment of Refractory Solid Tumors

Who this might be right for
Refractory Malignant Solid NeoplasmOsteosarcomaLeiomyosarcomas+4 more
City of Hope Medical Center 92
Testing effectiveness (Phase 2)Looking for participantsNCT07629960
What this trial is testing

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

Who this might be right for
Advanced Solid TumorNon-Small Cell Lung CancerColorectal Neoplasms+1 more
Blueprint Medicines Corporation 265
Early research (Phase 1)Study completedNCT04853017
What this trial is testing

ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors

Who this might be right for
Minimal Residual DiseaseKRAS G12DKRAS G12R+9 more
Elicio Therapeutics 25
Early research (Phase 1)Study completedNCT04752215
What this trial is testing

A Study Evaluating Different Doses of BI 765049 When Given Alone and When Given With Ezabenlimab to Patients With Advanced Solid Tumors Expressing the Protein B7-H6 on the Cell Surface

Who this might be right for
Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Pancreatic Neoplasms, Carcinoma, Hepatocellular, Head and Neck Neoplasms, Gastrointestinal Neoplasms
Boehringer Ingelheim 67
Early research (Phase 1)Looking for participantsNCT07317505
What this trial is testing

JMT108 in Participants With Advanced Solid Tumors

Who this might be right for
CancerCancer (Solid Tumors)
Conjupro Biotherapeutics, Inc. 270
Next Page